Fork it!

Cash Accruals Screen 16 Qualifying in UK

This screen is loosely based on the influential work of Richard Sloan from the University of Michigan, published in 1996 documenting what is referred to as the “accrual anomaly”. A pound of earnings can be comprised of assumed non-cash earnings called “accruals.” His landmark 1996 paper revealed that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones His paper found that investors focus too heavily on earnings and not on cash generation. They value the earnings of a high accrual company just as highly as the same earnings of a low accrual company, even though the high accrual company’s earnings are more likely to reverse in future years. When future earnings reverse, investors are “surprised” and sell off the stock causing the stock price to decline. Similarly, when a low accrual company’s earnings accelerate in future years, they are surprised in a good way. To learn more about this strategy please click here »

This is an independent study based upon the methods of...
Picture of Richard Sloan

Richard Sloan

Professor of Accounting, University of California (Berkeley). Amongst other research (e.g. R&D), he first identified the Accrual Anomaly.

Your Next Great Stock: How to Screen the Market for Tomorrow's Top Performers

by Jack Hough

Jack Hough highlighted this apporach in his excellent book, "Your Next Great Stock" (see link above). It is based on a 1996 University of Michigan study by Richard Sloan that found that buying companies with negative accruals and shorting negative accruals outperformed the market overall by 10% from 1962 to 1991. A subsequent study in 2006, "Cash Flows, Accruals and Future Returns" found that an accrual-based strategy beat the market by more than 9% a year.

This screen is based on a UK dataset. It uses the following criteria:

  • Mkt Cap £m > 150
  • OCF > Net Profit before Extraords
  • OCF PS > 0
  • EPS > 0
  • EPS 3y CAGR % > 15
  • EPS Gwth % > EPS 3y CAGR %
  • P/E < Median
  • Industry Group not in Collective Investments,

Results are sorted by:

  • Accrual Ratio in ascending order

And limited to the first 30 Results

Can these rules be improved? Submit a suggestion »
Want to make your own version? Create a Fork!

Performance Tracking

Returns FTSE 100
1 week -1.7% -1.3% 0.6% -3.8%
1 month -3.1% 1.7% 7.2% -2.5%
3 months 4.5% 7.4% 11.9% 3.5%
6 months 9.1% 6.4% 20.5% 1.9%
1 year 3.1% 2.9% - 2.4%
2 years 31.1% - - 5.6%
Annualised 22.4% 14.4% 31.3%
Max Drawdown -15.1% -12.9% -11.7%
Avg Holdings 11.9 23.8 25
Diversification Moderate Good Good

 Studies based on equal weighted portfolios of max 25 stocks rebalanced quarterly. Qualifying shares below updated daily. Past performance not indicative of future returns.

Please subscribe to see the companies that qualify for this independent study of the Cash Accruals Screen Strategy.
Plans start from as little as 25 per month. 14 day FREE TRIAL available.

16 Qualifying in

Ticker Name Mkt Cap £m OCF Net Profit before Extraords OCF PS EPS 3y CAGR % EPS Gwth % P/E Accrual Ratio Sector
Subscriber Subscriber Energy  
Subscriber Subscriber Energy  
Subscriber Subscriber Financials  
Subscriber Subscriber Consumer Defensives  
Subscriber Subscriber Energy  
Subscriber Subscriber Healthcare  
Subscriber Subscriber Financials  
Subscriber Subscriber Technology  
Subscriber Subscriber Basic Materials  
Subscriber Subscriber Consumer Defensives  
Subscriber Subscriber Financials  
Subscriber Subscriber Financials  
Subscriber Subscriber Financials  
Subscriber Subscriber Consumer Cyclicals  
Subscriber Subscriber Financials  
Subscriber Subscriber Financials  

Can't see the share you expect? View this screen as a checklist to find out why.

You should consider the results of any screening process, including this one, as candidates for further research, not as a buy list. Screening helps to narrow a search based on pre-defined criteria. It is not a substitute for independent research reflecting your individual criteria for investing/trading. Please note that the screening criteria used represents Stockopedia's interpretation of the author's investment approach and are not determined or endorsed by the original strategist.